We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Innovation Fund Boosts Commercialization of Purdue Technologies

News   Jan 31, 2013

 
Innovation Fund Boosts Commercialization of Purdue Technologies
 
 
 

RELATED ARTICLES

New Version of CAR T-Cell Therapy Eliminates Severe Side Effects

News

An advance in the breakthrough cancer treatment known as CAR T-cell therapy appears to eliminate its severe side effects, making the treatment safer and potentially available in outpatient settings, a new USC study shows.

READ MORE

3D Heart Printed Using Patient's Own Tissue

News

The engineered heart completely matches the immunological, cellular, biochemical and anatomical properties of the patient.

READ MORE

Could Persistent CD30 Signaling Lead to Blood Cancers?

News

Researchers have developed a mouse model to investigate whether persistent CD30 signaling leads to the development of blood cancers.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE